Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZtoMed is a U.S.-based digital health and precision medicine company that appears to combine telemedicine with genomics-driven clinical decision support. Public web references indicate the company has offered a patient-doctor video consultation app and has also developed DNAHealthMap, a platform focused on sequencing, analysis, and disease risk interpretation from DNA and RNA data. The business appears oriented toward preventive health, personalized medicine, and matching patients with clinicians while incorporating genomic information into care decisions. Available public information is sparse and fragmented, so ZtoMed seems better characterized as an early-stage health technology company than as a traditional therapeutic biotech developer with a disclosed drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZtoMed.